Author:
Aribi Ahmed,Kantarjian Hagop,Koller Charles,Thomas Deborah,Faderl Stefan,Garcia-Manero Guillermo,Cortes Jorge
Reference22 articles.
1. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med.,2006
2. Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment;Hochhaus;Blood.,2008
3. Efficacy and safety of bosutinib (SKI-606) among patients with chronic phase Ph + chronic myelogenous leukemia (CML);Cortes;Blood.,2007
4. Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy;Hochhaus;Blood.,2007
5. A phase I study of INNO-406 in patients with advanced Philadelphia (Ph +) chromosome-positive leukemias who are resistant or intolerant to imatinib and second generation tyrosine kinase inhibitors;Kantarjian;Blood.,2007
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献